Free Trial
LON:SAR

Sareum (SAR) Share Price, News & Analysis

Sareum logo
GBX 18.29 +0.29 (+1.61%)
As of 10:32 AM Eastern

About Sareum Stock (LON:SAR)

Key Stats

Today's Range
18.29
19
50-Day Range
13.66
20.65
52-Week Range
11
36
Volume
289,495 shs
Average Volume
433,476 shs
Market Capitalization
£22.85 million
P/E Ratio
N/A
Dividend Yield
1.10%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive SAR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sareum and its competitors with MarketBeat's FREE daily newsletter.

SAR Stock News Headlines

I warned you about Nvidia… now look what’s happening
Nvidia just got Trump’s greenlight to sell high-powered AI chips to China — and their stock surged 5% before the open. That’s the kind of move Tim Sykes built his XGPT system to trade. It scans AI news in real time, filters the noise, and pinpoints when to strike. He’s now showing exactly how it works — before the next headline hits.
Sareum Holdings Refocuses Strategy After SRA737 Licensing Termination
See More Headlines

SAR Stock Analysis - Frequently Asked Questions

Sareum's stock was trading at GBX 24.60 at the beginning of the year. Since then, SAR shares have decreased by 25.7% and is now trading at GBX 18.29.

Sareum Holdings plc (LON:SAR) released its earnings results on Tuesday, March, 25th. The company reported ($0.90) earnings per share for the quarter.

Shares of SAR stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Sareum investors own include ReNeuron Group (RENE), ValiRx (VAL), Sierra Oncology (SRRA), Egdon Resources (EDR), Collagen Solutions plc (COS.L) (COS), Gulf Keystone Petroleum (GKP) and Summit Therapeutics (SMMT).

Company Calendar

Last Earnings
3/25/2025
Today
7/18/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Biotechnology
Sub-Industry
Financial Services
Current Symbol
LON:SAR
CIK
N/A
Fax
N/A
Employees
3,211
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX (4.22)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-£5.28 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-270.25%
Return on Assets
-113.80%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
4.22
Quick Ratio
10.37

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
GBX 1.62 per share
Price / Cash Flow
11.32
Book Value
GBX 2.61 per share
Price / Book
7.01

Miscellaneous

Outstanding Shares
124,928,001
Free Float
N/A
Market Cap
£22.85 million
Optionable
Not Optionable
Beta
-1.08
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (LON:SAR) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners